Floatz logo

Calcium folinate pentahydrate

Ovarian Carcinosarcoma

ARCAGY/ GINECO GROUPSmall moleculePhase 2/3Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
89/ 100

Competitive context

16 Active assets in the Ovarian Carcinosarcoma cohort.

Asset / SponsorPhaseRating
(+)-VINCRISTINE
National Cancer Institute (NCI)
Phase 2BB
Irinotecan
National Cancer Institute (NCI)
Phase 2BB
CIS-DIAMMINEDICHLOROPLATINUM II
National Cancer Institute (NCI)
Phase 2BB
Carboplatin
University of Oklahoma
Phase 3BB
Inno-206
National Cancer Institute (NCI)
Phase 2B

View all 30 →

Same molecule, other indications

Calcium folinate pentahydrate is also rated in:

Advanced KRAS Positive Metastatic Colorectal CancerDormant
BBB
Indicative ·
78 / 100
View asset →
Recurrent Pancreatic CarcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
Stage IV Colon CancerDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →